Showing results (911-920 of 1,181) with videos related to

Sort By:
Pageof 119
Vox Sanguinis|March 21, 2020
Electronic charting of transfusion medicine consults: implementation, challenges and opportunitiesMohammad K Mohammad, Melanie S Wooten, Cheryl L Maier, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 6, 2025
HPV Workshop for Underserved High School StudentsDesiree Delavary, Lauran Evans, Carine Tamamian, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 29, 2024
Extraordinary Thermoelectric Properties of Topological Surface States in Quantum-Confined Cd3As2 Thin FilmsWenkai Ouyang, Alexander C Lygo, Yubi Chen, et al.
Behavioral Neuroscience|May 25, 2011
The risky business of dopamine agonists in Parkinson disease and impulse control disordersDaniel O Claassen, Wery P M van den Wildenberg, K Richard Ridderinkhof, et al.
Plos One|May 10, 2013
Fatty acid metabolites in rapidly proliferating breast cancerJoseph T O'Flaherty, Rhonda E Wooten, Michael P Samuel, et al.
Molecular & Cellular Proteomics : MCP|December 14, 2025
Validation of a mass spectrometry-based proteomics molecular pathology assayJessica R Chapman, Jeeyeon Baik, Oana Madalina Mereuta, et al.
Physics in Medicine and Biology|June 18, 2015
A framework for automated contour quality assurance in radiation therapy including adaptive techniquesM B Altman, J A Kavanaugh, H O Wooten, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2007
Unc-51-like kinase 1/2-mediated endocytic processes regulate filopodia extension and branching of sensory axonsXiang Zhou, J Ramesh Babu, Susana da Silva, et al.
Journal of the American Dietetic Association|July 29, 2008
Folate intake and food-related behaviors in nonpregnant, low-income women of childbearing ageEmily R Cena, Amy Block Joy, Karrie Heneman, et al.
The Journal of Urology|July 19, 2008
A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agentsNizar M Tannir, Peter F Thall, Chaan S Ng, et al.
Pageof 119